113 related articles for article (PubMed ID: 33149279)
1. Publisher Correction: Mutations and mechanisms of WNT pathway tumour suppressors in cancer.
Bugter JM; Fenderico N; Maurice MM
Nat Rev Cancer; 2021 Jan; 21(1):64. PubMed ID: 33149279
[No Abstract] [Full Text] [Related]
2. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
[TBL] [Abstract][Full Text] [Related]
3. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Cheng J; Demeulemeester J; Wedge DC; Vollan HKM; Pitt JJ; Russnes HG; Pandey BP; Nilsen G; Nord S; Bignell GR; White KP; Børresen-Dale AL; Campbell PJ; Kristensen VN; Stratton MR; Lingjærde OC; Moreau Y; Van Loo P
Nat Commun; 2017 Oct; 8(1):1221. PubMed ID: 29089486
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers.
Ying Y; Tao Q
Epigenetics; 2009 Jul; 4(5):307-312. PubMed ID: 28001119
[TBL] [Abstract][Full Text] [Related]
6. Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia.
Zhuo C; Wang D; Zhou C; Chen C; Li J; Tian H; Li S; Ji F; Liu C; Chen M; Zhang L
Front Mol Neurosci; 2019; 12():1. PubMed ID: 30809121
[TBL] [Abstract][Full Text] [Related]
7. Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.
Pospisil H; Herrmann A; Butherus K; Pirson S; Reich JG; Kemmner W
BMC Genomics; 2006 Jun; 7():148. PubMed ID: 16772034
[TBL] [Abstract][Full Text] [Related]
8. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
[TBL] [Abstract][Full Text] [Related]
9. Canonical WNT signalling determines lineage specificity in Wilms tumour.
Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.
Ying Y; Tao Q
Epigenetics; 2009 Jul; 4(5):307-12. PubMed ID: 19633433
[TBL] [Abstract][Full Text] [Related]
11. A novel role for the tumour suppressor Nitrilase1 modulating the Wnt/β-catenin signalling pathway.
Mittag S; Valenta T; Weiske J; Bloch L; Klingel S; Gradl D; Wetzel F; Chen Y; Petersen I; Basler K; Huber O
Cell Discov; 2016; 2():15039. PubMed ID: 27462437
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing within the Wnt signaling pathway: role in cancer development.
Sumithra B; Saxena U; Das AB
Cell Oncol (Dordr); 2016 Feb; 39(1):1-13. PubMed ID: 26762488
[TBL] [Abstract][Full Text] [Related]
14. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway.
Fu L; Zhang C; Zhang LY; Dong SS; Lu LH; Chen J; Dai Y; Li Y; Kong KL; Kwong DL; Guan XY
Gut; 2011 Dec; 60(12):1635-43. PubMed ID: 21672941
[TBL] [Abstract][Full Text] [Related]
15. Secreted WNT antagonists as tumor suppressors: pro and con.
Rubin JS; Barshishat-Kupper M; Feroze-Merzoug F; Xi ZF
Front Biosci; 2006 Sep; 11():2093-105. PubMed ID: 16720296
[TBL] [Abstract][Full Text] [Related]
16. The Role of Wnt Signaling in Squamous Cell Carcinoma.
Shiah SG; Shieh YS; Chang JY
J Dent Res; 2016 Feb; 95(2):129-34. PubMed ID: 26516128
[TBL] [Abstract][Full Text] [Related]
17. Wnt-β-catenin signalling in liver development, health and disease.
Perugorria MJ; Olaizola P; Labiano I; Esparza-Baquer A; Marzioni M; Marin JJG; Bujanda L; Banales JM
Nat Rev Gastroenterol Hepatol; 2019 Feb; 16(2):121-136. PubMed ID: 30451972
[TBL] [Abstract][Full Text] [Related]
18. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
[TBL] [Abstract][Full Text] [Related]
19. Publisher Correction: Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactor.
Tsimbouri PM; Childs PG; Pemberton GD; Yang J; Jayawarna V; Orapiriyakul W; Burgess K; González-García C; Blackburn G; Thomas D; Vallejo-Giraldo C; Biggs MJP; Curtis ASG; Salmerón-Sánchez M; Reid S; Dalby MJ
Nat Biomed Eng; 2017 Dec; 1(12):1004. PubMed ID: 31015702
[TBL] [Abstract][Full Text] [Related]
20. SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms.
Bhutia YD; Babu E; Ramachandran S; Yang S; Thangaraju M; Ganapathy V
Biochem J; 2016 May; 473(9):1113-24. PubMed ID: 27118869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
